Digital Institute for Cancer Outcomes Research

Our series of leadership seminars for the IDEAL4OMOP training programme continues. Our next seminar is on Tuesday 12th November at 6pm CET. We are delighted to welcome two eminent speakers: Prof Asieh Golozar, one of the leading lights in the OHDSI community, and Prof Andre Dekker, who is working at the forefront of technology and federated research. They will be sharing their experiences of innovation in healthcare research, as well as reflections on their own leadership journey. Members and friends of the DIGICORE community are all welcome – to receive an invitation to this and subsequent events, please contact [email protected]

Two inspiring days at the OHDSI (Observational Health Data Sciences & Informatics) Global Symposium 2024, New Brunswick, NJ, have come to an end. The symposium offered insightful considerations on what makes good real world evidence, showcased the power of large multi-institutional observational studies, and had highly interactive workgroup sessions on a variety of subjects. With emphasis on interdiciplinarity, broad international representation, and a unique combination of playfulness (quite literally) yet sincere dedication to good science, the OHDSI community creates engagement and enthusiasm. I was fortunate to present one of three DigiONE posters along with Jack Brewster and Lars S. Halvorsen: https://lnkd.in/gGBup8Zw  https://lnkd.in/gQ3p8vSz  https://lnkd.in/g__qdyeA Digital Institute for Cancer Outcomes Research, Piers Mahon, Åslaug Helland, Åsa Öjlert, Elisabeth Ross, Olivier Bouissou, Tasmeia Yousaf, Stelios Theophanous, Hayley Fenton, Aiara Lobo Gomes, Joelle Thonnard, Dr. Andrea Wolf, Geoff Hall, Alberto Traverso, Rosie McDonald, Jie Yeap, PhD and all other co-authors...

https://lnkd.in/ejHq5j7d

Just out!! Second report by European Medicines Agency on the use of #rwe for regulatory decision making. Great read including lots of info on studies performed during the 2nd year of #DARWINEU https://lnkd.in/eh-zKiua

Today, FDA issued the final guidance, "Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products": https://lnkd.in/geANjjW7 The guidance includes recommendations for sponsors and other interested parties proposing to use data from electronic health records (EHRs) or medical claims to help support a new use of an FDA-approved drug or biological product or to help support or satisfy post-approval study requirements.

Do check out "Haemato-oncology Highlights from Major Congresses 2024" organised by our friends at the SPCC (Sharing Progress in Cancer Care). The first webinar (CME accredited and free of charge) will follow the EHA Congress and will be on Tuesday, 23rd July 2024, at 18.00 CEST: https://lnkd.in/dMdYDx7n. This activity is supported by educational grants from Cloud Pathology Group and Eli Lilly and Company, but the companies have no control over its content.

We are pleased to inform you that SPCC is conducting webinars focusing on Breast Cancer Highlights and Lung Cancer Highlights from the ASCO Annual Meeting 2024.   Breast cancer highlights from the ASCO Annual Meeting 2024 - Monday, 17 June 2024 - 6.00 pm CEST Featuring Dr. Fatima Cardoso, Dr. Shani Paluch-Shimon, and Prof. Nadia Harbeck. Register here: https://lnkd.in/dQCqS8RT Lung cancer highlights from the ASCO Annual Meeting 2024 - Monday, 24th June 2024 - 4.30 pm CEST Featuring Dr. Alfredo Addeo, Dr. Xiuning Le, and Prof. Jarushka Naidoo Register here: https://lnkd.in/ebF_HFFD

📌 On Thursday 18th April, we held the first seminar of the #IDEAL4OMOP training programme. Over 70 participants (clinicians, data scientists, research managers, statisticians and others) from 14 countries and 40 separate organisations have now registered for this multi-year course. Participants will gain the skills and experience they need to become the digital oncology research leaders of the future, using OMOP standards, and aligning with the exciting work ongoing with the DIGICORE-I3 grant. 📌 The programme consists of a range of taught modules, covering both technical and leadership skills, and also a practical element: €300,000 will be awarded to participant teams to design and run their own studies – learning first-hand how to go from protocol concept to analytic outputs. 📌 Together with IDEAL4OMOP, we have now launched a parallel training programme, #MEDOC-ETL, which aims to support hospital data and IT colleagues in developing an OMOP research database in their organisation based on the DIGICORE MEDOC (“Minimum Essential Description of Cancer”) approach. 📌 This is open to all, but is proving to be of particular interest to sites in the DIGICORE-I3 programme, who will be working on implementing an OMOP instance in their centres. This course consists of two virtual webinars in May/June and a three-day face-to-face training event in Frankfurt in July. 🎓 To learn more about this programme, you can view the introductory seminar here 👉 https://lnkd.in/dZG9Kkje. All are welcome to attend the webinars, and there may still be spaces for the face-to-face training. ✉️ Feel free to contact [email protected] to receive more information about the training programmes 💯 Share this post and become a protagonist of cancer research development! #digicore #cancercare #cancerresearch #datascientists #medicaldata #trainingprogramme

🚩 We're pleased to announce that Elected Board Member Prof. Åslaug Helland from Oslo University Hospital (OUH) has been appointed as Treasurer. 👏 DIGICORE is grateful to have Prof. Helland continue contributing to our organization in this capacity. 💯 Share this post and become a protagonist of cancer research development!

🚩 We are happy to announce the appointment of Prof. Giovanni Tonon as the new President of DIGICORE. Prof. Tonon comes to us from Ospedale San Raffaele in Milan, Italy where he is the Director of the Center for Omics Sciences, and Head of the Functional Genomics of Cancer Unit. 🚩 Additionally, we are pleased to welcome Prof. Alessandro Sgambato from Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy and we welcome back Prof. Amaury Martin, PhD from Institut Curie in Paris, France as the newest members of our board. Their expertise and dedication will undoubtedly contribute to our strategic direction and growth. 👏 Let's give a warm welcome to our new leadership team as we embark on this exciting journey together! 🔗 To learn more about our new President and board members, visit our updated webpage https://lnkd.in/durNNFaP 💯 Share this post and become a protagonist of cancer research development! #cancercare #cancerresearch #boardmembers #leadership